Prognostic value of admission glucose in non-diabetic patients with myocardial infarction
- 22 September 2004
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 148 (3), 399-404
- https://doi.org/10.1016/j.ahj.2004.04.007
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trialsAmerican Heart Journal, 2003
- Screening for Type 2 DiabetesDiabetes Care, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Alterations in fuel metabolism in critical illness: hyperglycaemiaBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.Diabetes Care, 1999
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplastyClinical Cardiology, 1998
- Thrombolytic Therapy for Acute Myocardial InfarctionDrugs, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958